Responses

Download PDFPDF
Does dietary lutein and zeaxanthin increase the risk of age related macular degeneration? The Melbourne Visual Impairment Project
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Lutein, zeaxanthine, and AMD: Authors' response.
    • Hugh R Taylor, Professor of Ophthalmology
    • Other Contributors:
      • Luba Robman, Hien Vu, Catherine McCarty, and Allison Hodge

    Dear Editor

    Regarding the comments by Beaumont and Kang to our letter "Does dietary lutein and zeaxanthin increase the risk of age-related macular degeneration?" (Vu et al., BJO 2006;90:389), we feel that a dual standard is used in this letter to accept or reject data. How many of the case-control studies or cohort studies (that rely on self reported data on both exposure and outcome) that are used to support the...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Re: Dietary lutein and zeaxanthin (LZ) and the risk of age related macular degeneration?
    • Paul Beaumont, Medical retinal specialist
    • Other Contributors:
      • H. Kwon Kang
    Conflict of Interest:
    None declared.
  • Published on:
    Authors' response
    • Luba Robman
    • Other Contributors:
      • Allison Hodge, Catherine A McCarty, Hugh R Taylor

    Dear Editor,

    We were interested to see the letter by Mitchell et al, written in response to our earlier publication [1].

    Mitchell and co-workers raise several points, the first of which is the way one handles missing data. AMD can be assessed either clinically or photographically. Rather than throw away data and run the potential of bias by excluding patients who did not have a retinal photograph, we c...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Lutein and zeaxanthin dietary intake and age related macular degeneration
    • Paul Mitchell, Ophthalmologist
    • Other Contributors:
      • Victoria M Flood, Elena Rochtchina, Jie Jin Wang, Wayne Smith

    Lutein and Zeaxanthin dietary intake and age related macular degeneration

     

    We read with interest the letter published by Vu et al (1) whic...

    Show More
    Conflict of Interest:
    None declared.